Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Cell Point (India) IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2013 Industry: Trading Listed Page

Profile
Issue Size --
Profile
Price Range 100  to  100 per share
Profile
Min Investment ₹100
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Cell Point (India) Ltd is a prominent technology company based in India. With a focus on telecommunications and mobile services, the company has established itself as a leading provider of cutting-edge solutions and innovative products. Cell Point specializes in the development and manufacturing of advanced mobile devices, including smartphones, tablets, and wearable technology. The company's commitment to research and development enables them to deliver high-quality, feature-rich products that cater to the evolving needs of consumers. Cell Point's strong market presence and strategic partnerships have positioned them as a key player in the Indian mobile industry. By combining state-of-the-art technology, exceptional design, and reliable performance, Cell Point (India) Ltd continues to empower individuals and businesses with seamless connectivity and digital experiences. Read More

Basic Info

Face Value 10 per share

Price 100  to  100 per share

P/E (x) 83.3

Sales( Cr.) 325

PAT( Cr.) 2

EPS 1.2

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Mr. Mohan Prasad Panday Mr. Bala Balaji Panday

Pre Issue Share Holding 100%

Post Issue Share Holding 79.12%

Listing Details:

Listing Price: 100

Listing Gain: 0%

Current Price: 16.7

Gain On Issue: 16.7 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jun 15, 2023
Closing Date Jun 20, 2023
Allotment Jun 21, 2023
Refund Jun 22, 2023
Delivery of Shares Jun 22, 2023
Listing Date Jun 23, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1200 120,000
Retail (Max) 1 1200 120,000
S-HNI (Min) 2 2400 240,000
S-HNI (Max) 8 9600 960,000
B-HNI (Min) 9 10800 1,080,000

Objective of the Issue

1. Repayment of certain borrowings 2. Repairs and Renovation of existing retail outlets & amp amp amp amp amp amp setting of new retail outlets 3. To meet the Working Capital requirements 4. General Corporate Expenses 5. Issue Expenses

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 0 0 0x
Retail 0 0 0x
EMP 0 0 0x
Total 5034000 30355020 6x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Cell Point (India) Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 278 223 269 296 321 325
Other Income 1 1 1 1 2 2
Total Income 278 224 270 297 323 326
Total Expenditure 268 215 258 278 313 317
Operating Profit 10 8 12 19 10 9
Interest 6 6 8 9 6 5
Depreciation 2 1 1 1 2 3
Exceptional Income / Expenses 0 0 0 0 0 2
Profit Before Tax 2 1 2 10 3 3
Provision for Tax 1 1 1 3 1 1
Profit After Tax 2 1 2 7 2 2
Adjustments 0 0 0 0 0 0
Profit After Adjustments 2 1 2 7 2 2
Adjusted Earnings Per Share 12.9 5.6 13.3 4.9 0.9 1.2

Cell Point (India) Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 11 12 13 20 72 74
Minority's Interest 0 0 0 0 0 0
Borrowings 22 24 20 18 1 1
Other Non-Current Liabilities -1 -1 -1 -1 -1 0
Total Current Liabilities 23 30 50 56 61 62
Total Liabilities 55 64 83 94 134 138
Fixed Assets 19 19 19 18 33 37
Other Non-Current Assets 5 13 13 15 29 22
Total Current Assets 31 32 51 61 72 79
Total Assets 55 64 83 94 134 138

Cell Point (India) Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 3 3 8 10 12
Cash Flow from Operating Activities 1 2 -0 7 -7 -1
Cash Flow from Investing Activities -1 -1 -0 -0 -31 2
Cash Flow from Financing Activities 1 -0 5 -4 39 -7
Net Cash Inflow / Outflow 1 1 5 2 2 -6
Closing Cash & Cash Equivalent 3 3 8 10 12 6

Cell Point (India) Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 12.89 5.57 13.27 4.93 0.91 1.21
CEPS(Rs) 25.21 15.27 22.3 5.62 1.9 2.94
DPS(Rs) 0 0 0 0 0.25 0
Book NAV/Share(Rs) 88.81 94.38 107.65 14.71 38.6 39.74
Core EBITDA Margin(%) 3.41 3.5 4.01 6.09 2.69 2.25
EBIT Margin(%) 3.06 3.2 3.92 6.22 2.63 2.46
Pre Tax Margin(%) 0.86 0.57 0.9 3.34 0.85 0.87
PAT Margin (%) 0.58 0.31 0.61 2.27 0.53 0.7
Cash Profit Margin (%) 1.13 0.85 1.03 2.59 1.11 1.69
ROA(%) 2.92 1.16 2.24 7.62 1.49 1.67
ROE(%) 14.51 6.08 13.13 40.22 3.67 3.09
ROCE(%) 21.05 15.75 18.29 26.08 8.6 6.65
Receivable days 0.89 0.76 0.48 0.36 0.3 0.89
Inventory Days 25.89 37.16 43.23 51.82 57.39 66.74
Payable days 19.15 21.53 18.87 18.44 13.71 15.69
PER(x) 0 0 0 0 35.48 13.18
Price/Book(x) 0 0 0 0 0.83 0.4
Dividend Yield(%) 0 0 0 0 0.78 0
EV/Net Sales(x) 0.1 0.16 0.17 0.2 0.3 0.21
EV/Core EBITDA(x) 2.76 4.35 3.84 3.06 9.38 7.73
Net Sales Growth(%) 0 -19.65 20.69 9.85 8.65 1.08
EBIT Growth(%) 0 -15.89 47.86 74.38 -54 -5.58
PAT Growth(%) 0 -56.8 138.21 308.5 -74.82 33.56
EPS Growth(%) 0 -56.8 138.21 -62.86 -81.6 33.56
Debt/Equity(x) 2.66 3.29 3.87 2.78 0.68 0.61
Current Ratio(x) 1.35 1.08 1.01 1.08 1.18 1.26
Quick Ratio(x) 0.49 0.21 0.26 0.26 0.27 0.24
Interest Cover(x) 1.39 1.22 1.3 2.16 1.47 1.54
Total Debt/Mcap(x) 0 0 0 0 0.81 1.52

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 7% 3% 0%
Operating Profit CAGR -10% -9% -2% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -11% NA% NA% NA%
ROE Average 3% 16% 13% 13%
ROCE Average 7% 14% 15% 16%

Company Contact Information

Cell Point (India) Ltd.

Door No 30-15-139/ F/5,6 Ward No 27, Ram’s Arcade Opposite Visakha Medical Centre, Dabagardens

IPO Lead Manager(s)

Cell Point (India) Ltd.

First Overseas Capital Limited

Registrar Info

Cell Point (India) Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!